PF560 A MATURATION INDEX DEFINES NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH ADVANCED IMMUNOPHENOTYPIC AND MOLECULAR DIFFERENTIATION PROFILES ASSOCIATED WITH POOR PROGNOSIS

Authors :: Marina Martello
L. Agboyi
P. Tacchetti
A. Poletti
M. Cavo
G. Chirumbolo
Giulia Marzocchi
A. Orlando
Enrica Borsi
R. Termini
Nicoletta Testoni
M. Arpinati
V. Solli
L. Cifarelli
Carolina Terragna
Giovanni Martinelli
Lucia Pantani
S. Rocchi
K. Mancuso
Elena Zamagni
Source :: HemaSphere. 3:232
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Oncology
medicine.medical_specialty
Poor prognosis
Index (economics)
business.industry
Internal medicine
medicine
Hematology
Newly diagnosed
business
medicine.disease
Multiple myeloma

Tools